Scolaris Content Display Scolaris Content Display

Exercise therapy for patellofemoral pain syndrome

Esta versión no es la más reciente

Contraer todo Desplegar todo

Referencias

References to studies included in this review

Clark 2000 {published data only}

Clark DI, Downing N, Mitchell J, Coulson L, Syzpryt EP, Doherty M. Physiotherapy for anterior knee pain: a randomised controlled trial. Annals of the Rheumatic Diseases 2000;59(9):700‐4. [MEDLINE: PMID: 10976083]

Colón 1988 {published data only}

Colón VF, Mangine R, McKnight C, Kues J. The pogo stick in rehabilitating patients with patellofemoral chondrosis. Journal of Rehabilitation 1988;54(1):73‐7.

Dursun 2001 {published data only}

Dursun N, Dursun E, Kilic Z. Electromyographic biofeedback‐controlled exercise versus conservative care for patellofemoral pain syndrome. Archives of Physical Medicine and Rehabilitation 2001;82(12):1692‐5. [MEDLINE: PMID: 11733884]

Gaffney 1992 {published data only}

Gaffney K, Fricker P, Dwyer T, Barrett E, Skibinski K, Coutts R. Patellofemoral joint pain: a comparison of two treatment programmes. Excel 1992;8:179‐89.

Gobelet 2001 {published data only}

Gobelet C, Frey M, Bonard A. Muscle training techniques and retropatellar chondropathy [Techniques de musculation et chondropathie rétro‐patellaire]. Revue du Rhumatisme et des Maladies Osteo‐Articulaires 1992;59(1):23‐7.

Harrison 1999 {published data only}

Harrison EL, Sheppard MS, McQuarrie AM. A randomized controlled trial of physical therapy treatment programs in patellofemoral pain syndrome. Physiotherapy Canada 1999;51(2):93‐100, 106.

McMullen 1990 {published data only}

McMullen W, Roncarati A, Koval P. Static and isokinetic treatments of chondromalacia patella: A comparative investigation. Journal of Orthopaedic & Sports Physical Therapy 1990;12(6):256‐66. [EMBASE AN: 1991001330]

Stiene 1996 {published data only}

Stiene HA, Brosky T, Reinking MF, Nyland J, Mason MB. A comparison of closed kinetic chain and isokinetic joint isolation exercise in patients with patellofemoral dysfunction. Journal of Orthopaedic & Sports Physical Therapy 1996;24(3):136‐41. [MEDLINE: PMID: 8866272]

Thomee 1997 {published data only}

Thomee R. A comprehensive treatment approach for patellofemoral pain syndrome in young women. Physical Therapy 1997;77(12):1690‐703. [MEDLINE: PMID: 9413448]

Timm 1998 {published data only}

Timm KE. Randomized controlled trial of Protonics on patellar pain, position, and function. Medicine and Science in Sports and Exercise 1998;30(5):665‐70. [MEDLINE: PMID: 9588606]

Wijnen 1996 {published data only}

Wijnen LCAM, Lenssen AF, Kuys‐Wouters YMS, De Bie RA, Borghouts JAJ, Bulstra SK. McConnell therapy versus Coumans bandage for patellofemoral pain ‐ a randomised pilot study [McConnell‐therapie versus Coumans‐bandage bij patellofemorale pijnklachten ‐ een gerandomiseerde pilotstudie]. Nederlands Tijdschrift voor fysiotherapie 1996;Sept(Special):12‐17.

Witvrouw 2000 {published data only}

Witvrouw E, Lysens R, Bellemans J, Peers K, Vanderstraeten G. Open versus closed kinetic chain exercises for patellofemoral pain. A prospective, randomized study. American Journal of Sports Medicine 2000;28(5):687‐94. [MEDLINE: PMID: 11032226]

References to studies excluded from this review

Beetsma 1996 {unpublished data only}

Beetsma AJ, Zomerdijk TE, van Horn JR, Van Wijck R. Functional treatment of the patellofemoral pain syndrome in adolescent girls ‐ is the McConnell program efficacious? ‐ a pilot study. Acta Orthopedica Scandinavia. Supplementum 1996;68(274):25.

Eburne 1996 {published data only}

Eburne J, Bannister G. The McConnell regimen versus isometric quadriceps exercises in the management of anterior knee pain. A randomised prospective controlled trial. The Knee 1996;3:151‐3.

Kowall 1996 {published data only}

Kowall MG, Kolk G, Nuber GW, Cassisi JE, Stern SH. Patellar taping in the treatment of patellofemoral pain. A prospective randomized study. American Journal of Sports Medicine 1996;24(1):60‐6. [MEDLINE: PMID: 8638755]

Roush 2000 {published data only}

Roush MB, Sevier TL, Wilson JK, Jenkinson DM, Helfst RH, Gehlsen GM, et al. Anterior knee pain: a clinical comparison of rehabilitation methods. Clinical Journal of Sport Medicine 2000;10(1):22‐8. [MEDLINE: PMID: 10695846]

References to studies awaiting assessment

Crossley 2002 {published data only}

Crossley K, Bennell K, Green S, Cowan S, McConnell J. Physical therapy for patellofemoral pain: a randomized, double‐blinded, placebo‐controlled trial. American Journal of Sports Medicine 2002;30(6):857‐65. [MEDLINE: PMID: 12435653]

Arnoldi 1991

Arnoldi CC. Patellar pain. Acta Orthopaedica Scandinavica. Supplementum 1991;244:1‐29. [MEDLINE: 1882690]

Arroll 1997

Arroll B, Ellis‐Pegler E, Edwards A, Sutcliffe G. Patellofemoral pain syndrome. A critical review of the clinical trials on nonoperative therapy. American Journal of Sports Medicine 1997;25(2):207‐12. [MEDLINE: PMID: 9079175]

Bourne 1988

Bourne MH, Hazel WA, Scott SG, Sim FH. Anterior knee pain. Mayo Clinic Proceedings 1988;63(5):482‐91. [MEDLINE: 3283473]

Clarke 2003a

Clarke M, Oxman AD, editors. MEDLINE highly sensitive search strategy for OVID‐MEDLINE. Cochrane Reviewers' Handbook 4.2.0 [updated March 2003]; Appendix 5b2. In: The Cochrane Library [database on disk and CDROM]. The Cochrane Collaboration. Oxford: Update Software; 2003, issue 2.

Clarke 2003b

Clarke M, Oxman AD, editors. Assessment of study quality. Cochrane Reviewers' Handbook 4.2.0 [updated March 2003]; Section 6. In: The Cochrane Library [database on disk and CDROM]. The Cochrane Collaboration. Oxford: Update Software; 2003, issue 2.

Cutbill 1997

Cutbill JW, Ladly KO, Bray RC, Thorne P, Verhoef M. Anterior knee pain: a review. Clinical Journal of Sports Medicine 1997;7(1):40‐5. [MEDLINE: PMID: 9117525]

Fairbank 1984

Fairbank JC, Pynsent PB, van Poortvliet JA, Phillips H. Mechanical factors in teh incidence of knee pain in adolescents and young adults. Journal of Bone and Joint Surgery. British Volume 1984;66(5):685‐93. [MEDLINE: PMID: 6501361]

Gerrard 1990

Gerrard B. The patellofemoral pain syndrome: A clinical trial of the McConnell programme. Physiotherapy 1990;76(9):559‐65.

Gilleard 1998

Gilleard W, McConnell J, Parsons D. The effect of patellar taping on the onset of vastus medialis obliquus and vastus lateralis muscle activity in persons with patellofemoral pain. Physical Therapy 1998;78(1):25‐32.

Goodfellow 1976

Goodfellow J, Hungerford DS, Woods C. Patello‐femoral joint mechanics and pathology. 2. Chondromalacia patellae. Journal of Bone & Joint Surgery ‐ British Volume 1976;58(3):291‐9. [MEDLINE: PMID: 956244]

Grelsamer 1998

Grelsamer RP, Klein JR. The biomechanics of the patellofemoral joint. Journal of Orthopaedic and Sports Physical Therapy 1998;28(5):286‐98. [MEDLINE: PMID: 9809277]

Holmes 1998

Holmes SW, Glancy WG. Clinical classification of patellofemoral pain and dysfunction. Journal of Orthopaedic and Sports Physical Therapy 1998;28(5):299‐306. [MEDLINE: PMID: 9809278]

Juhn 1999

Juhn MS. Patellofemoral pain syndrome: a review and guidelines for treatment. American Family Physician 1999;60(7):2012‐22. [MEDLINE: PMID: 10569504]

Kannus 1994

Kannus P, Niittymaki S. Which factors predict outcome in the nonoperative treatment of patellofemoral pain syndrome? A prospective follow‐up study. Medicine & Science in Sports & Exercise 1994;26(3):289‐296. [MEDLINE: PMID: 8183092]

McConnell 1986

McConnell J. The management of chondromalacia patellae: A long term solution. Australian Journal of Physiotherapy 1986;32:215‐23.

McNally 2001

McNally EG. Imaging assessment of anterior knee pain and patellar maltracking. Skeletal Radiology 2001;30(9):484‐95. [MEDLINE: PMID: 11587516]

Natri 1998

Natri A, Kannus P, Jarvinen M. Which factors predict the long‐term outcome in chronic patellofemoral pain syndrome? A 7‐yr prospective follow‐up study. Medicine & Science in Sports & Exercise 1998;30(11):1572‐77. [MEDLINE: PMID: 9813868]

Nissen 1998

Nissen CW, Cullen MC, Hewett TE, Noyes FR. Physical and arthroscopic examination techniques of the patellofemoral joint. Journal of Orthopaedic and Sports Physical Therapy 1998;28(5):277‐85. [MEDLINE: PMID: 9809276]

Powers 1998

Powers CM. Rehabilitation of patellofemoral joint disorders: a critical review. Journal of Orthopaedic and Sports Physical Therapy 1998;28(5):345‐53. [MEDLINE: PMID: 9809282]

Powers 2000

Powers CM. Patellar kinematics, part I: the influence of vastus muscle activity in subjects with and without patellofemoral pain. Physical Therapy 2000;80(10):956‐64. [MEDLINE: PMID: 11002431]

Puniello 1993

Puniello MS. Iliotibial band tightness and medial patellar glide in patients with patellofemoral dysfunction. Journal of Orthopaedic and Sports Physical Therapy 1993;17(3):144‐48. [MEDLINE: PMID: 8472078]

RevMan 2000 [Computer program]

The Cochrane Collaboration. Review Manager (RevMan). Version 4.1 for Windows. Oxford, England: The Cochrane Collaboration, 2000.

Shelton 1991

Shelton GL, Thigpen LK. Rehabilitation of patellofemoral dysfunction: a review of literature. Journal of Orthopaedic and Sports Physical Therapy 1991;14(6):243‐49.

Thomee 1999

Thomee R, Augustsson J, Karlsson J. Patellofemoral pain syndrome: a review of current issues. Sports Medicine 1999;28(4):245‐62. [MEDLINE: PMID: 10565551]

van Tulder 1997

van Tulder MW, Assendelft WJ, Koes BW, Bouter LM. Method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group for spinal disorders. Spine 1997;22(20):2223‐30. [MEDLINE: PMID: 9355211]

van Tulder 2001

van Tulder MW, Jellema P, van Poppel MN, Nachemson AL, Bouter LM. Lumbar supports for prevention and treatment of low back pain (Cochrane review). Cochrane Database of Systematic Reviews 2001, Issue 4. [CD001823]

Verhagen 1998

Verhagen AP, de Vet HC, de Bie RA, Kessels AG, Boers M, Bouter LM, et al. The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. Journal of Clinical Epidemiology 1998;51(12):1235‐41. [MEDLINE: PMID: 10086815]

Wilk 1998

Wilk KE, Davies GJ, Mangine RE, Malone TR. Patellofemoral disorders: a classification system and clinical guidelines for nonoperative rehabilitation. Journal of Orthopaedic and Sports Physical Therapy 1998;28(5):307‐22. [MEDLINE: PMID: 9809279]

Witvrouw 2000a

Witvrouw E, Lysens R, Bellemans J, Peers K, Vanderstraeten G. Open versus closed kinetic chain exercises for patellofemoral pain. A prospective, randomized study. American Journal of Sports Medicine 2000;28(5):687‐94. [MEDLINE: PMID: 11032226]

Witvrouw 2000b

Witvrouw E, Lysens R, Bellemans J, Cambier D, Vanderstraeten G. Intrinsic risk factors for the development of anterior knee pain in an athletic population. A two‐year prospective study. American Journal of Sports Medicine 2000;28(4):480‐9. [MEDLINE: PMID: 10921638]

Zomerdijk 1998

Zomerdijk TE, Beetsma AJ, Dekker R, Van Wijck R, Van Horn JR. Conservative treatment of the Patellofemoral Pain syndrome ‐a systematic review of literature [Conservatieve behandeling van het patellofemoraal pijnsyndroom ‐een systematisch literatuuronderzoek]. Nederlands tijdschrift voor fysiotherapie 1998;108(4):95‐102.

Characteristics of studies

Characteristics of included studies [ordered by study ID]

Clark 2000

Methods

RCT
Computer generated randomisation

High quality: Delphi score 6

Participants

AKP/PFPS, median duration >12 months (<3 to >12)
Patients referred from orthopaedic/rheumatology consultants/GPs
81 patients, 56% male
Age 26.0 ± 7.4 (15‐40)

1) n=20
2) n=20
3) n=19
4) n=22

Interventions

Duration 3 months, 6 sessions
1) education, exercise, tape
2) education, exercise
3) education, tape
4) education

Education: background of PFPS
Exercise: 3 months 6 sessions and training at home: eccentric/isotonic strengthening exercises: bicycle warm‐up, wall squats gradually lengthened up to 3 min., sit to stand, proprioceptive balance, exercise gluteus muscles, progressive step down,
Tape: first three sessions, thereafter optional

Outcomes

VAS pain: baseline, 3 months, 12 months
1) 75.6 ±32.6, 35.9 ±28.7, 35.1±45.1
2) 77.1 ±44.4, 30.0 ±39.9, 37.8 ±43.4
3) 83.9 ±39.8, 57.8 ±38.7, 77.3 ±62.8
4) 77.0 ±41.8, 41.8 ±40.6, 51.9 ±53.8
WOMAC: baseline, 3 months, 12 months
1) 25.2 ±12.5, 11.5 ±10.5, 14.8 ±18.0
2) 23.7 ±12.9, 10.0 ±11.8, 15.6 ±16.2
3) 33.4 ±16.8, 20.9 ±15.5, 27.6 ±22.7
4) 28.7 ±15.4, 13.8 ±15.8, 22.0 ±21.3
Patient satisfaction expressed as N discharged: 3 months
1) 19=95% 2) 20=100% 3) 8=42% 4) 13=59%
Patient recovery expressed as N still troubled: 12 months
1) 6=60% 2) 7=58% 3) 9=75% 4) 13=87%
Patient recovery expressed as N continuing therapy: 12 months
1) 2=10% 2) 2=10% 3) 3=16% 4) 5=23%

Notes

Drop‐outs:
1) 3 months: 4 patients
12 months: 10 patients
2) 3 months: 4 patients
12 months: 8 patients
3) 3 months: 1 patient
12 months: 7 patients
4) 3 months: 1 patient
12 months: 7 patients

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Low risk

A ‐ Adequate

Colón 1988

Methods

RCT
Quasi random, matching for age, physical findings and disability

Low quality: Delphi score 3

Participants

PFPS, mild or moderate
Recreational athletes
29 patients, 66% male
Age (15‐24)

1) n=13
2) n=16

Interventions

Duration 6‐8 weeks,
Stretching*, ice application after exercise
1) Pogo stick bounces (isometric exercise + endurance training), incremental increase from 250 bounces twice daily up to 10 minutes
2) Conservative isometric exercises: straight leg raises with increasing weights, bicycling

Outcomes

Baseline, 6‐8 weeks:
N >50% improved on 11‐point pain scale:
1) 9 (82%)
2) 13 (93%)

Notes

1) 2 withdrawals: 1 female increased pain, 1 male vacation interruptions,
2) 2 female withdrawals, no description

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Dursun 2001

Methods

RCT
Randomisation method not specified

Low quality: Delphi score 4

Participants

PFPS, all unilateral, duration: 10 ± 8 months
Outpatient clinic of university medical faculty physical medicine and rehabilitation

60 patients, 20% male
Age: 37 ± 10 (17‐50)

1) n=30
2) n=30

Interventions

Conventional exercise program: 4 weeks 5 days/week supervised, total duration not stated. Biofeedback 4 weeks, 3 times per week.
Stretching*, proprioception training, endurance training with bicycle
1) conventional open and closed kinetic chain exercise with electromyographic feedback
2) conventional open and closed kinetic chain exercise (n=30)

Outcomes

VAS pain: baseline, 1, 2, 3 months
1) 7.5 ±1.6, 4.3 ±1.4, 2.2 ±1.8, 1.2 ±0.6
2) 7.3 ±1.5, 3.7 ±1.7, 2.0 ±1.2, 0.7 ±1.1
FIQ: baseline, 1, 2, 3 months
1) 8.3 ±1.8, 12.0 ±1.7, 13.4 ±2.0, 15.1 ±1.4
2) 7.9 ±1.8, 12.8 ±2.0, 14.3 ±1.5, 15.2 ±1.2

Notes

No drop outs

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Gaffney 1992

Methods

RCT
Randomisation method not specified

Low quality: Delphi score 3

Participants

PFPS/chondromalacia, 50% bilateral
Duration of complaints 40.7 months
72 patients, 65% male
Age: 34 (11‐65)

1) n=36
2) n=36

Interventions

Duration 6 weeks, weekly visits to check correct performance all groups, stretching retinaculum before taping
1) pain free eccentric and isometric exercise with taping (squats, steps with gradually increasing speed, height of step and weights (hand/rucksack))
2) concentric isometric exercise (quadriceps setting, straight leg raises and knee extensions)

Outcomes

VAS pain baseline, 6 weeks:
1) 6.07, 2.86
2) 5.81, 2.64
Function grade 6 weeks:
1) improved=18, no change=4, variable=6
2) improved=15, no change=7, variable=10
Clarke's test positive baseline, 6 weeks:
1) 20 (28%), 8 (14%)
2) 28 (39%), 11 (17%)
Individual's opinion of success 6 weeks:
1) 25 (89%)
2) 24 (75%)

Notes

1) 8 withdrawals
2) 4 withdrawals

Descriptions:
1: too far to attend
2: another injury
2: work commitments/travel
7: unknown

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Gobelet 2001

Methods

RCT
Randomisation method not specified

Low quality: Delphi score 1

Participants

Chondropathy, type Wyberg I or II (not III), with or without dysplasia of the patella

40 patients per group were included, analysed were following numbers:
1) n=28
2) n=40
3) n=26

Interventions

Duration 4 weeks,
All groups ice application
1) at home electro stimulation of quadriceps with memory card for compliance, 4 hours a day
2) pain free isokinetic training at 30°/s and 300°/s, 3 times a week 25‐30 minutes
3) proprioceptive static exercise,
stretching* all structures, 3 times a week 30‐45 minutes

Outcomes

Arpège function scale: baseline, 4 weeks
1) 11.1 ±3.9, 14.4 ±2.69
2) 12.8 ±3.1, 15.5 ±2.6
3) 10.8 ±3.7, 15.1 ±2.3

Notes

Drop out reasons:
10 incomplete
4 non compliance with instructions
12 stopped because of ineffectiveness of treatment.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

D ‐ Not used

Harrison 1999

Methods

RCT
Random number table, application not specified

Low quality: Delphi score 3

Participants

PFPS, 54% bilateral, 15% of patients limitations in activities
referred from GPs and orthopaedic surgeons
112 patients, 40% male,
Age: 22.2 ± 8.2 (12‐35)

1) n=42
2) n=34
3) n=36

Interventions

Duration 4 weeks,
All groups ice application after exercise, stretching
1) conservative home exercise: straight leg raises with progressive weights, knee extensions, education on background PFPS
2) similar program monitored by physiotherapist, education background PFPS, supervision 3 times weekly
3) exercises with patellar taping and biofeedback progressive exercises: stride standing, standing with foot supination, step downs, plié squats, wall squats, optional adductor strengthening
supervision 3 times weekly, home exercise

Outcomes

VAS 3 days average of worst pain: baseline, 1, 3, 6, 12 months
1) 4.58 ±2.51, 2.96 ±2.28,2.62 ±2.95, 3.11 ±3.45, 2.01 ±3.18
2) 4.68 ±2.48, 3.60 ±2.31, 2.40 ±2.53, 2.20 ±2.58, 2.21 ±2.83
3) 4.39 ±2.39, 1.99 ±2.06, 2.93 ±2.49, 1.65 ±1.77, 1.80 ±2.83
FIQ (0 worst, 16 best score)
number of patients with score 0‐4, 5‐8, 9‐12, 13‐16:
1) baseline: 0,7,15,12
1 month: 0,1,10,13
12 months: 0,3,4,12
2) baseline: 3,10,7,10
1 month: 1,5,12,8
12 months: 0,0,2,11
3) baseline: 0,6,10,14
1 month: 0,3,8,17
12 months: 0,2,4,14
PFS (0 worst ‐100 best):
baseline, 1, 3, 6, 12 months
1) 54 ±15, 64 ±19, 65±18, 73 ±19, 75 ±17
2) 54 ±13, 58 ±16, 65 ±15, 71 ±16, 82 ±11
3) 51 ±12, 68 ±16, 68 ±16, 73 ±19, 81 ±17
Perceived change in condition at 1 month:
none/worse, some improvement, significant improvement
1) 6, 14, 9,
2) 10, 13, 6
3) 2, 6, 17
Seconds of step test until pain: baseline, 1, 3, 6, 12 months
1) 106 ±110, 169 ±126, 188 ±121, 224 ±117, 211 ±123
2) 120 ±105, 154 ±117, 235 ±105, 231 ±115, 260 ±94
3) 131 ±106, 206 ±106, 235 ±95, 236 ±108, 265 ±90

Notes

In particular patients with good results at 1 month dropped out

Number of patients 0, 1, 3, 6, 12 months:
1) 33 23 22 14 18
2) 31 26 20 15 13
3) 29 25 20 23 18

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

McMullen 1990

Methods

CCT
Geographical location dictated group assignment

Low quality: Delphi score 3

Participants

Chondromalacia, all unilateral,
Duration of complaint: 4.07 ± 2.52 (1‐8 months)
29 patients, 55% male
Age: 28.12 ± 9.96
1) n=9
2) n=11
3) n=9

Interventions

Duration 4 weeks
1) waiting list control, weekly telephone contact
2) static exercise, stretching hamstrings,
12 sessions in 4 weeks
3) isokinetic exercise, 12 sessions in 4 weeks

Outcomes

CRS, overall activity level: 4 weeks
1) 10.92
2) 14.82
3) 13.86

Notes

No drop‐outs

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

D ‐ Not used

Stiene 1996

Methods

CCT
Treatment assigned by investigator with attempts to balance for functional rating and patellar dislocation

Low quality: Delphi score 1

Participants

PFPS,
Sports Medicine Center
33 patients included, characteristics stated of 23 patients: 39 % male
Age: 19 ± 6

1) n=11
duration symptoms
13.1 ± 12.2 months,
4 luxations

2) n=12
duration symptoms
31.9 ± 31.8 months,
3 luxations

Interventions

Duration 8 weeks
Week 1: stretching only, from week 2 exercise three days per week
1) joint isolation isokinetic exercise: velocity spectrum from 180º/s to 360º/s with 30º/s increments
2) closed kinetic chain exercise: squats, lateral and retro step‐ups with increasing dumbbell resistance, progression to stair‐master exercise

Outcomes

Retro step repetitions until intolerance of symptomatic leg
(including patients with luxations): baseline, 8, 52 weeks
1) 2.5 ±2.3, 4.3 ±1.7, 6.7 ±3.5
2) 3.2 ±2.4, 18.6 ±11.9, 27.3 ±12.5
Questionnaire (without patients with luxations):
baseline, 6 months, 1 year
1) excellent 0, 0, 0
good 2, 1, 2
fair 5, 5, 4
poor 0, 1, 1
2) excellent 0, 1, 6
good 1, 4, 1
fair 6, 4, 2
poor 2, 0, 0

Notes

1) 6 drop‐outs
2) 4 drop‐outs
due to <70% of training sessions attended

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

D ‐ Not used

Thomee 1997

Methods

RCT
Odd‐even number treatment allocation

Low quality: Delphi score 3

Participants

PFPS, 27% bilateral, 75% pain with sports,
Duration: 43 ± 31.2 (6‐108) months
Referred by orthopaedic surgeons
40 female patients,
Age: 20.2 ± 3.2 (15‐28)

1) n=20
2) n=20

Interventions

Duration: 3 sessions to familiarise with training, 12 weeks training, 3 days per week during week 1 and 2, thereafter 2 days per week

1) isometric exercise
2) eccentric exercise

Outcomes

Number of patients participating in sports with/without pain: 0, 3, 12 months
1) 13/0, 3/9, 1/17
2) 17/0, 5/11, 1/17
Number of subjects experiencing pain: 0, 3, 12 months
1) Jogging 16 (80%),12 (60%), 6 (30%)
Heavy loading 17 (85%), 11(55%), 5 (25%)
At rest after activity 18 (90%), 7 (35%), 1 (5%)
2) Jogging 18 (90%), 9 (45%), 4 (20%)
Heavy loading 17 (85%), 12 (60%), 5 (25%)
At rest after activity 16 (80%), 6 (30%),1 (5%)

Notes

No drop‐outs reported

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Timm 1998

Methods

RCT
Odd‐even number treatment allocation

Low quality: Delphi score 3

Participants

PFPS, all unilateral, duration: 12.5 ± 5 weeks (5‐19)
Referred from orthopaedic surgeons
100 patients, 60% male
Age: 30 ± 6 (24 ‐ 44)
1) n=50
2) n=50

Interventions

4 weeks duration, daily use of Protonics® device
1) Protonics® device: high volume submaximal concentric contractions of quadriceps and hamstrings
2) no treatment

Outcomes

VAS pain: baseline, 4 weeks
1) 6.50 ±1.07, 3.54 ±0.97
2) 6.54 ±0.97, 6.74 ±1.05
KPFS: baseline, 4 weeks
1) 41.72 ±4.21, 86.76 ±6.65
2) 41.42 ±3.87, 41.20 ±3.95

Notes

No drop‐outs reported

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Wijnen 1996

Methods

RCT
Randomisation by independent person in blocks of 4 persons, prestratified for gender and duration of symptoms (< or < 1 year)

High quality: Delphi score 6

Participants

PFPS,
Duration: 32 (4 ‐ 96)
Orthopaedic outpatient clinic
18 patients, 28% male
Age: 22 (16‐37)

1) n=7
2) n=8

Interventions

Duration 6 weeks: group 1 group 2 home exercise intensity not specified
1) McConnell regimen with individual exercise program. 12 sessions twice weekly and twice daily home training
2) Coumans bandage with standard home exercise schedule

Outcomes

11‐point pain scale walking stairs, mean (min‐max): baseline, 6 weeks
1) 6.3 (1‐10), 4.4 (1‐7)
2) 5.3 (0‐8), 4.1 (0‐9)
11‐point pain scale sitting with knees bent, mean (min‐max): baseline, 6 weeks
1) 6.3 (1‐10), 1.9 (0‐6)
2) 5.3 (0‐8), 4.3 (0‐10)
11‐point pain scale squatting, mean (min‐max): baseline, 6 weeks
1) 6.3 (1‐10), 5.1 (0‐10)
2) 5.3 (0‐8), 6.0 (0‐10)
KPFS: baseline, 6 weeks
1) 58.3 (28‐84), 84 (60‐96)
2) 64.6 (39‐84), 74.1 (43‐89)
Ranawat function score: baseline, 6 weeks
1) 74.4 (38‐97), 95 (81‐100)
2) 79.0 (58‐97), 85.3 (58‐100)
11‐point scale patient satisfaction with therapy: 6 weeks
1) 7.6 (6‐9)
2) 4.3 (0‐9)
11‐point scale patient satisfaction with recovery: 6 weeks
1) 6.1 (4‐9)
2) 3.4 (0‐8)

Notes

Drop‐outs
1) 1 patient did not show up, 1 patient found quadriceps contraction too painful
2) 1 patient could not tolerate Coumans bandage

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Low risk

A ‐ Adequate

Witvrouw 2000

Methods

RCT
Randomisation using sealed envelopes

High quality: Delphi score 6

Participants

PFPS, 45% bilateral, duration: 15.1 (0.5 ‐ 28) months
Physical therapy department of hospital
60 patients
Age: 20.3 (14‐33),

1) n=30
2) n=30

Interventions

Duration: 5 weeks, three days per week
1) open kinetic chain exercise: maximal static quadriceps muscle contractions in full extension, straight leg raises in supine position, short arc terminal knee extensions, leg adductions in lateral decubitus position
2) closed kinetic chain exercise: seated leg presses, one‐third knee bends on one and both legs, stationary bicycling, rowing‐machine exercises, step‐up and step‐down, progressive jumping

Outcomes

VAS pain during daily activity: baseline, 5 weeks, 3 months
1) 5.4 ±2.2, 3.7 ±1.6, 3.9 ±1.5
2) 5.5 ±2.3, 4.0 ±1.6, 3.0 ±1.0
VAS pain during triple jump test: baseline, 5 weeks, 3 months
1) 2.5 ±7, 1.4 ±4, 0.9 ±2
2) 2.4 ±6, 1.3 ±4, 1.0 ±3
KPFS: baseline, 5 weeks, 3 months
1) 68 ±35, 83 ±37, 87 ±40
2) 68 ±34, 80 ±37, 84 ±39
N without symptoms during functional tests:
Unilateral squat: baseline, 5 weeks, 3 months
1) 6 (20%), 11 (37%), 16 (53%)
2) 6 (20%), 13 (43%), 17 (57%)
Step‐up: baseline, 5 weeks, 3 months
1) 11 (37%), 23 (77%), 22 (73%)
2) 8 (27%), 18 (60%), 22 (73%)
Step‐down: baseline, 5 weeks, 3 months
1) 8 (27%), 19 (63%), 23 (77%)
2) 5 (17%), 12 (40%), 20 (67%)

Notes

No drop‐outs

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Low risk

A ‐ Adequate

*stretching exercises usually focus on knee flexors and extensors and iliotibial band, sometimes patellar retinaculum

ABBREVIATIONS AND ACRONYMS
AKP: anterior knee pain
PFPS: patellofemoral pain syndrome
GP: General Practitioner
RCT: randomised controlled trial
CCT: concurrent controlled trial
VAS: visual analogue scale
WOMAC: osteoarthritis index, measuring pain, disability and stiffness of the knee or hip
FIQ: functional index questionnaire
KPFS: Kujala patellofemoral function scale
CRS: Cincinnati rating scale

Characteristics of excluded studies [ordered by study ID]

Study

Reason for exclusion

Beetsma 1996

Publication was not full text article, contact with third author did not yield data.

Eburne 1996

Description of results insufficient.

Kowall 1996

The contrast between both exercising treatment groups existed of taping of the patella, which is not the aim of this review.

Roush 2000

Number of patients with plica syndrome, Osgood Schlatter and tendinitis not mentioned, no subgroups reported.
The results were too poorly reported.

Data and analyses

Open in table viewer
Comparison 1. Exercise versus no exercise

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Pain, continuous data Show forest plot

2

Mean Difference (IV, Random, 95% CI)

Totals not selected

Analysis 1.1

Comparison 1 Exercise versus no exercise, Outcome 1 Pain, continuous data.

Comparison 1 Exercise versus no exercise, Outcome 1 Pain, continuous data.

1.1 VAS: 1 month

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

1.2 VAS: 3 months

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

1.3 VAS: 12 months

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

2 Function, continuous data Show forest plot

3

Mean Difference (IV, Random, 95% CI)

Totals not selected

Analysis 1.2

Comparison 1 Exercise versus no exercise, Outcome 2 Function, continuous data.

Comparison 1 Exercise versus no exercise, Outcome 2 Function, continuous data.

2.1 Cincinnatti overall activity level: 1 month, static exercise versus no exercise

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

2.2 Cincinnatti overall activity level: 1 month, isokinetic exercise versus no exercise

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

2.3 Kujala Patellofemoral Scale: 1 month

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

2.4 100 ‐ WOMAC = inversed WOMAC scale: 3 months

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

2.5 100 ‐ WOMAC = inversed WOMAC scale: 12 months

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

3 Recovery, dichotomous data Show forest plot

1

Risk Ratio (M‐H, Random, 95% CI)

Totals not selected

Analysis 1.3

Comparison 1 Exercise versus no exercise, Outcome 3 Recovery, dichotomous data.

Comparison 1 Exercise versus no exercise, Outcome 3 Recovery, dichotomous data.

3.1 Number of patients discharged from therapy because of patient's satisfaction, 3 months

1

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

3.2 Number of patients no longer troubled by symptoms, 12 months

1

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

3.3 Number of patients discontinuing therapy after 12 months

1

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

Open in table viewer
Comparison 2. Closed kinetic chain versus open kinetic chain

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Pain, continuous data Show forest plot

3

Mean Difference (IV, Random, 95% CI)

Totals not selected

Analysis 2.1

Comparison 2 Closed kinetic chain versus open kinetic chain, Outcome 1 Pain, continuous data.

Comparison 2 Closed kinetic chain versus open kinetic chain, Outcome 1 Pain, continuous data.

1.1 VAS: 6 weeks

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

1.2 VAS walking stairs: 6 weeks

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

1.3 VAS sitting with knees bent: 6 weeks

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

1.4 VAS bending knees: 6 weeks

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

1.5 VAS during triple jump test: 5 weeks

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

1.6 VAS during daily activity: 5 weeks

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

1.7 VAS during triple jump test: 3 months

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

1.8 VAS during daily activity: 3 months

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

2 Pain, dichotomous data Show forest plot

1

Risk Ratio (M‐H, Random, 95% CI)

Totals not selected

Analysis 2.2

Comparison 2 Closed kinetic chain versus open kinetic chain, Outcome 2 Pain, dichotomous data.

Comparison 2 Closed kinetic chain versus open kinetic chain, Outcome 2 Pain, dichotomous data.

2.1 >50% improvement: 6‐8 weeks

1

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

3 Function, continuous data Show forest plot

3

Mean Difference (IV, Random, 95% CI)

Totals not selected

Analysis 2.3

Comparison 2 Closed kinetic chain versus open kinetic chain, Outcome 3 Function, continuous data.

Comparison 2 Closed kinetic chain versus open kinetic chain, Outcome 3 Function, continuous data.

3.1 Kujala Patellofemoral Scale: ± 6 weeks

2

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

3.2 Kujala Patellofemoral Scale: 3 months

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

3.3 Number of retro‐step repetitions until painful: 8 weeks

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

3.4 Number of retro‐step repetitions until painful: 1 year

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

4 Function, dichotomous data Show forest plot

2

Risk Ratio (M‐H, Random, 95% CI)

Totals not selected

Analysis 2.4

Comparison 2 Closed kinetic chain versus open kinetic chain, Outcome 4 Function, dichotomous data.

Comparison 2 Closed kinetic chain versus open kinetic chain, Outcome 4 Function, dichotomous data.

4.1 Overall assessment of function ‐ number of patients improved: 6 weeks

1

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

4.2 Asymptomatic patients in unilateral squat test: 5 weeks

1

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

4.3 Asymptomatic patients in step up test: 5 weeks

1

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

4.4 Asymptomatic patients in step down test: 5 weeks

1

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

4.5 Asymptomatic patients in unilateral squat test: 3 months

1

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

4.6 Asymptomatic patients in step up test: 3 months

1

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

4.7 Asymptomatic patients in step down test: 3 months

1

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

5 Function, categorical data Show forest plot

Other data

No numeric data

Analysis 2.5

Study

Months

Rating

Closed kinetic chain

Open kinetic chain

Function Index Questionnaire: 6 months

Stiene 1996

6

poor (0‐4)
fair (5‐8)
good (9‐12)
excellent (13‐16)

0
4
7
1

1
8
2
0

Stiene 1996

Function Index Questionnaire: 12 months

Stiene 1996

12

poor (0‐4)
fair (5‐8)
good (9‐12)
excellent (13‐16)

0
2
3
7

1
6
4
0

Stiene 1996



Comparison 2 Closed kinetic chain versus open kinetic chain, Outcome 5 Function, categorical data.

5.1 Function Index Questionnaire: 6 months

Other data

No numeric data

5.2 Function Index Questionnaire: 12 months

Other data

No numeric data

6 Global assessment, 11‐point scale, continuous data Show forest plot

1

Mean Difference (IV, Random, 95% CI)

Totals not selected

Analysis 2.6

Comparison 2 Closed kinetic chain versus open kinetic chain, Outcome 6 Global assessment, 11‐point scale, continuous data.

Comparison 2 Closed kinetic chain versus open kinetic chain, Outcome 6 Global assessment, 11‐point scale, continuous data.

6.1 Satisfaction with therapy: 6 weeks

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

6.2 Satisfaction with recovery: 6 weeks

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

7 Global assessments, dichotomous data Show forest plot

1

Risk Ratio (M‐H, Random, 95% CI)

Totals not selected

Analysis 2.7

Comparison 2 Closed kinetic chain versus open kinetic chain, Outcome 7 Global assessments, dichotomous data.

Comparison 2 Closed kinetic chain versus open kinetic chain, Outcome 7 Global assessments, dichotomous data.

7.1 Treatment success: 6 weeks

1

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

Methodological quality scores after consensus meeting
Figuras y tablas -
Figure 1

Methodological quality scores after consensus meeting

Comparison 1 Exercise versus no exercise, Outcome 1 Pain, continuous data.
Figuras y tablas -
Analysis 1.1

Comparison 1 Exercise versus no exercise, Outcome 1 Pain, continuous data.

Comparison 1 Exercise versus no exercise, Outcome 2 Function, continuous data.
Figuras y tablas -
Analysis 1.2

Comparison 1 Exercise versus no exercise, Outcome 2 Function, continuous data.

Comparison 1 Exercise versus no exercise, Outcome 3 Recovery, dichotomous data.
Figuras y tablas -
Analysis 1.3

Comparison 1 Exercise versus no exercise, Outcome 3 Recovery, dichotomous data.

Comparison 2 Closed kinetic chain versus open kinetic chain, Outcome 1 Pain, continuous data.
Figuras y tablas -
Analysis 2.1

Comparison 2 Closed kinetic chain versus open kinetic chain, Outcome 1 Pain, continuous data.

Comparison 2 Closed kinetic chain versus open kinetic chain, Outcome 2 Pain, dichotomous data.
Figuras y tablas -
Analysis 2.2

Comparison 2 Closed kinetic chain versus open kinetic chain, Outcome 2 Pain, dichotomous data.

Comparison 2 Closed kinetic chain versus open kinetic chain, Outcome 3 Function, continuous data.
Figuras y tablas -
Analysis 2.3

Comparison 2 Closed kinetic chain versus open kinetic chain, Outcome 3 Function, continuous data.

Comparison 2 Closed kinetic chain versus open kinetic chain, Outcome 4 Function, dichotomous data.
Figuras y tablas -
Analysis 2.4

Comparison 2 Closed kinetic chain versus open kinetic chain, Outcome 4 Function, dichotomous data.

Study

Months

Rating

Closed kinetic chain

Open kinetic chain

Function Index Questionnaire: 6 months

Stiene 1996

6

poor (0‐4)
fair (5‐8)
good (9‐12)
excellent (13‐16)

0
4
7
1

1
8
2
0

Stiene 1996

Function Index Questionnaire: 12 months

Stiene 1996

12

poor (0‐4)
fair (5‐8)
good (9‐12)
excellent (13‐16)

0
2
3
7

1
6
4
0

Stiene 1996

Figuras y tablas -
Analysis 2.5

Comparison 2 Closed kinetic chain versus open kinetic chain, Outcome 5 Function, categorical data.

Comparison 2 Closed kinetic chain versus open kinetic chain, Outcome 6 Global assessment, 11‐point scale, continuous data.
Figuras y tablas -
Analysis 2.6

Comparison 2 Closed kinetic chain versus open kinetic chain, Outcome 6 Global assessment, 11‐point scale, continuous data.

Comparison 2 Closed kinetic chain versus open kinetic chain, Outcome 7 Global assessments, dichotomous data.
Figuras y tablas -
Analysis 2.7

Comparison 2 Closed kinetic chain versus open kinetic chain, Outcome 7 Global assessments, dichotomous data.

Table 1. Quality assessment tool

Item

Score

Notes

D1. Was a method of randomisation performed?

2 = yes, clearly described method of randomisation
1 = unclear whether treatment allocation was truly random
0 = no, prospective study or other design without (quasi‐)random assignment

Cochrane code (Clarke 2003b): Clearly yes = A; Not sure = B; Clearly no = C

M‐A. (D2) Was the assigned treatment adequately concealed prior to allocation?

2 = method did not allow disclosure of assignment
1 = small but possible chance of disclosure of assignment or unclear
0 = quasi‐randomised or open list/tables

M‐B. (D9) Were the outcomes of patients who withdrew described and included in the analysis (intention‐to‐treat)?

2 = withdrawals well described and accounted for in analysis
1 = withdrawals described and analysis not possible
0 = no mention, inadequate mention or obvious differences and no adjustment

M‐C. (D5) Were the outcome assessors blinded to treatment status?

2 = effective action taken to blind assessors
1 = small or moderate chance of unblinding of assessors
0 = not mentioned or not possible

M‐D. (D3) Were the treatment and control group comparable at entry?

2 = good comparability of groups, or confounding adjusted for in analysis
1 = confounding small; mentioned but not adjusted for
0 = large potential for confounding, or not discussed

M‐E. (D7) Were the participants blind to assignment status after allocation?

2 = effective action taken to blind participants
1 = small or moderate chance of unblinding participants
0 = not possible, or not mentioned (unless double‐blind), or possible but not done

M‐F. (D6) Were the treatment providers blind to assignment status after allocation?

2 = effective action taken to blind treatment providers
1 = small or moderate chance of unblinding of treatment providers
0 = not possible, or not mentioned (unless double‐blind), or possible but not done

M‐G. Were care programmes, other than the trial options, identical?

2 = care programmes clearly identical
1 = clear but trivial differences
0 = not mentioned or clear and important differences in care programmes

M‐H. (D4) Were the inclusion and exclusion criteria clearly defined?

2 = clearly defined
1 = inadequately defined
0 = not defined

M‐I. Were the interventions clearly defined?

2 = clearly defined interventions are applied with a standardised protocol
1 = clearly defined interventions are applied but the application protocol is not standardised
0 = intervention and/or application poorly or not defined

M‐J. Were the outcome measures used clearly defined?

2 = clearly defined
1 = inadequately defined
0 = not defined

M‐K. Were diagnostic tests used in outcome assessment clinically useful? (by outcome)

2 = optimal
1 = adequate
0 = not defined, not adequate

M‐L. Was the surveillance active and of clinically appropriate duration?

2 = active surveillance and appropriate duration (>three weeks)
1 = active surveillance, but inadequate duration (<three weeks)
0 = surveillance not active or not defined

D8. Were point estimates and measures of variability presented for the primary outcome measures?

2 = point estimates and measures of variability presented
1 = point estimates, but no measures of variability presented
0 = only vague descriptions of outcome measures presented

T. Was the compliance rate in each group unlikely to cause bias?

2 = compliance well described and accounted for in analysis
1 = compliance well described but differences between groups not accounted for in analysis
0 = compliance unclear

X. Was a predefined set of diagnostic criteria provided for the included participants?

2 = clear description of diagnosis as well as diagnostic criteria were provided, or clear diagnostic exclusion criteria were provided
(e.g. 'chondromalacia', defined by the presence of lesions in patellar cartilage determined at arthroscopy)
1 = only diagnosis without criteria was provided (e.g. 'chondromalacia') and no clear diagnostic exclusion criteria were provided
0 = neither clear diagnosis nor criteria or symptoms were provided (e.g. 'anterior knee pain')

In this Table, items beginning with 'D' denote items from the Delphi‐list, while those beginning with 'M' denote items taken from the Cochrane Bone, Joint and Muscle Trauma Group methodological quality assessment tool and 'T' denotes the item from the Maastricht‐Amsterdam consensus list for Methodological Quality Assessment. In view of the diversity of diagnostic terms used for PFPS, one more item was added for scoring whether a predefined set of diagnostic criteria was provided in the study. This criterion is denoted with 'X'.

Figuras y tablas -
Table 1. Quality assessment tool
Table 2. Exercise versus no exercise

Study ID

Outcome measure

Instrument

Weeks

N exercise

Change (%) or N

N no exercise

Change (%) or N

Mean diff. (95% CI)

Stat. sign.?

Clark 2000

Pain

VAS (0‐100 mm)

13

32

‐34.4 ±41.6 (45%)*
individual changes
averaged by author

39

‐26.8 ±43.8 (43%)*
individual changes
averaged by author

‐7.6 (‐28 ‐ 12.9)

no

52

22

‐39.8 (52%)*
as calculated
from means

27

‐17.0 (21%)*
as calculated
from means

Not reported†
significance stated

yes

Function

WOMAC

13

32

‐11.7 ±12.4 (48%)*
individual changes
averaged by author

39

‐13.4 ±14.2 (33%)*
individual changes
averaged by author

1.7 (‐4.7 ‐ 8.1)

no

52

22

‐9.4 (38%)*
as calculated
from means

27

‐6.4 (21%)*
as calculated
from means

Not reported
no significance
mentioned

no

Patient
satisfaction

Discharge from
therapy

13

40

39*

31

21*

OR = 1.90
(1.41 ‐ 2.58) †
NNT=3(1.6‐3.3)

yes

Recovery

No longer troubled

52

22

9

27

5

OR = 2.21
(0.87 ‐ 5.64)

no

Recovery

Discontinuing therapy

52

22

18

27

19

OR = 1.16
(0.85 ‐ 1.59)

no

McMullen 1990

Pain

VAS (0‐10 cm)

4

"No change"

"No change"

no

Function

Overall activity level (CRS)
static vs control)

4

11

Medium effect size

9

Small effect size

yes

Isokinetic vs control

4

9

Medium effect size

yes

Timm 1998

Pain

VAS (0‐10 cm)

4

50

‐2.96 (47%)*

50

+0.20 (0.03%)

‐3.16†

yes

Function

KPFS

4

50

+45.04 (108%)*

50

‐0.22 (0.01%)

45.26†

yes

* = significant
change from
baseline
NS = not significant
† = significant
difference
between therapies

VAS=Visual Analog Scale
KPFS=Kujala
Patellofemoral
Function Scale
CRS=Cincinnatti
Rating Scale

RR=Relative Risk
NNT=Number needed
to treat

Figuras y tablas -
Table 2. Exercise versus no exercise
Table 3. Open versus closed kinetic chain exercise

Study ID

Outcome

Instrument

Weeks

N open chain

Change (%)

N closed chain

Change (%)

Mean diff. (95% CI)

Stat. sign.?

Witvrouw 2000

Pain

VAS (0‐100 mm)
triple jump test

5

30

‐11.5 (‐46%)*

30

‐11.0 (‐46%)*

0.5

no

13

30

‐16.1 (‐64%)*

30

‐13.3 (‐56%)*

2.8

no

VAS (0‐100 mm)
daily activity

5

30

‐17.0 (‐31%)*

30

‐15.0 (‐27%)*

2

no

13

30

‐15.0 (‐28%)*

30

‐25.0 (‐45%)*

‐10

no

Function

KPFS

5

30

+12 (18%)*

30

+15 (22%)*

3

no

13

30

+16 (24%)*

30

+19 (28%)*

3

no

N asymptomatic
unilateral squat

5

30

+5 (83%)*

30

+7 (117%)*

RR = 1.52
(0.41 ‐ 5.62)

no

13

30

+10 (167%)*

30

+11 (183%)*

RR = 1.16
(0.39 ‐ 3.42)

no

N asymptomatic
step up

5

30

+12 (109%)*

30

+10 (125%)*

RR = 0.75
(0.26 ‐ 2.20)

no

13

30

+11 (100%)*

30

+14 (175%)*

RR = 1.51
(0.53 ‐ 4.33)

no

N asymptomatic
step down

5

30

+11 (138%)*

30

+7 (140%)*

RR = 0.53
(0.17 ‐ 1.66)

no

13

30

+15 (188%)*

30

+15 (300%)*

RR = 1.00
(0.36 ‐ 2.81)

no

Wijnen 1996

Pain

VAS (0‐10)
walking stairs

6

7

‐1.2 (‐23%)

8

‐1.9 (‐30%)

0.3 (‐2.66 ‐ 3.26)

no

VAS (0‐10)
sitting with knees bent

6

7

‐0.5 (‐10%)

8

‐2.7 (‐59%)

‐2.4 (‐10.6 ‐ 5.84)

no

VAS (0‐10)
squatting

6

7

+0.4 (7%)

8

‐2.6 (‐34%)

‐0.9 (‐2.30 ‐ 0.50)

no

Function

KPFS

6

7

+9.5 (15%)

8

+25.7 (44%)

9.9 (‐2.32 ‐ 22.12)

no

Ranawat scale

6

7

+6.3 (8%)

8

+20.6 (28%)

9.7 (‐3.72 ‐ 23.12)

no

Satisfaction

VAS (0‐10)
with therapy

6

7

4.3

8

7.6

3.3 (0.32 ‐ 6.28)†

yes?

VAS (0‐10)
with recovery

6

7

3.4

8

6.1

2.7 (0.24 ‐ 5.46)

no

Stiene 1996

Function

Retro‐step
repetitions

8

12

+1.8 (72%)

11

+15.4 (481%)*

13.6†

yes

52

12

+4.2 (168%)

11

+24.1 (753%)*

19.9†

yes

Gaffney 1992

Pain

VAS (0‐10)

6

?

‐3.17 (55%)*

?

‐3.21 (53%)*

0.04

no

Function

N improved

6

32

15 (47%)*

28

18 (64%)*

RR = 1.37
(0.87 ‐ 2.17)

no

Satisfaction

N treatment succes

6

32

24 (75%)*

28

25 (89%)*

RR = 1.19
(0.94 ‐ 1.51)

no

Colòn 1988

Pain

N improved > 50%

6‐8

11

9 (82%)*

14

13 (93%)*

RR = 1.13
(0.83 ‐ 1.55)

no

* = significant
change from
baseline
NS = not significant
† = significant
difference
between therapies

VAS=Visual Analog Scale
KPFS=Kujala
Patellofemoral
Function Scale

Figuras y tablas -
Table 3. Open versus closed kinetic chain exercise
Comparison 1. Exercise versus no exercise

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Pain, continuous data Show forest plot

2

Mean Difference (IV, Random, 95% CI)

Totals not selected

1.1 VAS: 1 month

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

1.2 VAS: 3 months

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

1.3 VAS: 12 months

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

2 Function, continuous data Show forest plot

3

Mean Difference (IV, Random, 95% CI)

Totals not selected

2.1 Cincinnatti overall activity level: 1 month, static exercise versus no exercise

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

2.2 Cincinnatti overall activity level: 1 month, isokinetic exercise versus no exercise

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

2.3 Kujala Patellofemoral Scale: 1 month

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

2.4 100 ‐ WOMAC = inversed WOMAC scale: 3 months

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

2.5 100 ‐ WOMAC = inversed WOMAC scale: 12 months

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

3 Recovery, dichotomous data Show forest plot

1

Risk Ratio (M‐H, Random, 95% CI)

Totals not selected

3.1 Number of patients discharged from therapy because of patient's satisfaction, 3 months

1

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

3.2 Number of patients no longer troubled by symptoms, 12 months

1

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

3.3 Number of patients discontinuing therapy after 12 months

1

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

Figuras y tablas -
Comparison 1. Exercise versus no exercise
Comparison 2. Closed kinetic chain versus open kinetic chain

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Pain, continuous data Show forest plot

3

Mean Difference (IV, Random, 95% CI)

Totals not selected

1.1 VAS: 6 weeks

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

1.2 VAS walking stairs: 6 weeks

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

1.3 VAS sitting with knees bent: 6 weeks

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

1.4 VAS bending knees: 6 weeks

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

1.5 VAS during triple jump test: 5 weeks

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

1.6 VAS during daily activity: 5 weeks

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

1.7 VAS during triple jump test: 3 months

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

1.8 VAS during daily activity: 3 months

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

2 Pain, dichotomous data Show forest plot

1

Risk Ratio (M‐H, Random, 95% CI)

Totals not selected

2.1 >50% improvement: 6‐8 weeks

1

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

3 Function, continuous data Show forest plot

3

Mean Difference (IV, Random, 95% CI)

Totals not selected

3.1 Kujala Patellofemoral Scale: ± 6 weeks

2

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

3.2 Kujala Patellofemoral Scale: 3 months

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

3.3 Number of retro‐step repetitions until painful: 8 weeks

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

3.4 Number of retro‐step repetitions until painful: 1 year

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

4 Function, dichotomous data Show forest plot

2

Risk Ratio (M‐H, Random, 95% CI)

Totals not selected

4.1 Overall assessment of function ‐ number of patients improved: 6 weeks

1

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

4.2 Asymptomatic patients in unilateral squat test: 5 weeks

1

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

4.3 Asymptomatic patients in step up test: 5 weeks

1

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

4.4 Asymptomatic patients in step down test: 5 weeks

1

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

4.5 Asymptomatic patients in unilateral squat test: 3 months

1

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

4.6 Asymptomatic patients in step up test: 3 months

1

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

4.7 Asymptomatic patients in step down test: 3 months

1

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

5 Function, categorical data Show forest plot

Other data

No numeric data

5.1 Function Index Questionnaire: 6 months

Other data

No numeric data

5.2 Function Index Questionnaire: 12 months

Other data

No numeric data

6 Global assessment, 11‐point scale, continuous data Show forest plot

1

Mean Difference (IV, Random, 95% CI)

Totals not selected

6.1 Satisfaction with therapy: 6 weeks

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

6.2 Satisfaction with recovery: 6 weeks

1

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

7 Global assessments, dichotomous data Show forest plot

1

Risk Ratio (M‐H, Random, 95% CI)

Totals not selected

7.1 Treatment success: 6 weeks

1

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

Figuras y tablas -
Comparison 2. Closed kinetic chain versus open kinetic chain